Serum One-Carbon Metabolites and Risk of Cervical Cancer

REFERENCES

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 61, 69–90, 2011.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers CD, et al.:. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer, 2010. Available at: http://globocan.iarc.fr. 2010
   Google Scholar
• Schiffman MH and Castle P: Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 95, E2, 2003.
   PubMedGoogle Scholar
• Johnston C: Quantitative tests for human papillomavirus. Lancet 355, 2179–2180, 2000.
   PubMed Web of Science ®Google Scholar
• Ziegler RG, Weinstein SJ, and Fears TR: Nutritional and genetic inefficiencies in one-carbon metabolism and cervical cancer risk. J Nutr 132(8 Suppl), 2345S–2349S, 2002.
   PubMed Web of Science ®Google Scholar
• Whitehead N, Reyner F, and Lindenbaum J: Megaloblastic changes in the cervical epithelium: association with oral contraceptive therapy and reversal with folic acid. JAMA 226, 1421–1424, 1973.
   PubMed Web of Science ®Google Scholar
• Antony AC, Tang YS, Khan RA, Biju MP, Xiao X, et al.: Translational up-regulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions. J Clin Invest 113, 285–301, 2004.
   PubMedGoogle Scholar
• Pillai MR, Chacko P, Kesari LA, Jayaprakash PG, Jayaram HN, et al.: Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer. J Clin Pathol 56, 569–574, 2003.
   PubMed Web of Science ®Google Scholar
• Collier B, Goobar-Larsson L, Sokolowski M, and Schwartz S: Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J Biol Chem 273, 22648–22656, 1998.
   PubMed Web of Science ®Google Scholar
• Datta P, Bhatla N, Dar L, Patro AR, Gulati A, et al.: Prevalence of human papillomavirus infection among young women in North India. Cancer Epidemiol 34, 157–161, 2010.
   PubMed Web of Science ®Google Scholar
• Singh A, Datta P, Jain SK, Bhatla N, Dutta Gupta S, et al.: Human papilloma virus genotyping, variants and viral load in tumors, squamous intraepithelial lesions, and controls in a north Indian population subset. Int J Gynecol Cancer 19, 1642–1648, 2009.
   PubMed Web of Science ®Google Scholar
• Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, et al.: Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer. PLoS One 6(5), e19213, 2011.
   PubMed Web of Science ®Google Scholar
• Pathak S, Sharma C, Jayaram HN, and Singh N: Apoptotic signaling induced by benzamide riboside: an in vitro study. Mol Cell Biochem 328, 67–73, 2009.
   PubMed Web of Science ®Google Scholar
• Bajpai D, Banerjee A, Pathak S, Jain SK, and Singh N: Decreased expression of DNA repair genes (XRCC1, ERCC1, ERCC2, and ERCC4) in squamous intraepithelial lesion and invasive squamous cell carcinoma of the cervix. Mol Cell Biochem 377, 45–53, 2013.
   PubMed Web of Science ®Google Scholar
• Chaudhury A, Hussey GS, and Howe PH: 3’-UTR-mediated post-transcriptional regulation of cancer metastasis: beginning at the end. RNA Biol 8, 595–599, 2011.
   PubMed Web of Science ®Google Scholar
• Hussey GS, Chaudhury A, Dawson AE, Lindner DJ, Knudsen CR, et al.: Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol Cell 41, 419–431, 2011.
   PubMed Web of Science ®Google Scholar
• Sun XL and Antony AC: Evidence that a specific interaction between an 18-base cis-element in the 5’ untranslated region of human folate receptor-mRNA and a 46-kDa cytosolic trans-factor is critical for translation. J Biol Chem 271, 25539–25547, 1996.
   PubMed Web of Science ®Google Scholar
• Xiao X, Tang YS, Mackins JY, Sun XL, Jayaram HN,et al.: Isolation and characterization of a folate receptor mRNA-binding trans-factor from human placenta: Evidence favoring identity with heterogeneous nuclear ribonucleoprotein E1. J Biol Chem 276, 41510–41517, 2001.
   PubMed Web of Science ®Google Scholar
• Tang YS, Khan RA, Zhang Y, Xiao S, Wang M, et al.: Incrimination of heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) as a candidate sensor of physiological folate deficiency. J Biol Chem 286, 39100–39115, 2011.
   PubMed Web of Science ®Google Scholar
• Yemelyanova A, Gravitt PE, Ronnett BM, Rositch AF, Ogurtsova A, et al.: Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management. Mod Pathol. [Epub ahead of print] doi:10.1038/modpathol.2012.156
   Web of Science ®Google Scholar
• Zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92, 690–698, 2000.
   PubMed Web of Science ®Google Scholar
• Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, et al.: International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518–527, 2003.
   PubMed Web of Science ®Google Scholar
• Durst M, Bosch FX, Glitz D, Schneider A, and zur Hausen H: Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse mouse epithelial cysts and tumors induced by HPV-positive human cell lines. J Virol 65, 796–804, 1991.
   PubMed Web of Science ®Google Scholar
• Kulmala SM, Syrjänen SM, Gyllensten UB, Shabalova IP, Petrovichev N, et al.: Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 59, 513–517, 2006.
   PubMed Web of Science ®Google Scholar
• Arias-Pulido H, Peyton CL, Joste NE, Vargas H, and Wheeler CM: Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44, 1755–1762, 2006.
   PubMed Web of Science ®Google Scholar
• Fontaine J, Hankins C, Mayrand M, Lefevre J, Money D, et al.: High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. AIDS 19, 785–794, 2005.
   PubMed Web of Science ®Google Scholar
• Gallo G, Bibbo M, Bagella L, Zamparelli A, Sanseverino F, et al.: Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol 56, 532–536, 2003.
   PubMed Web of Science ®Google Scholar
• Peitsaro P, Johansson B, and Syrjanen S: Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40, 886–891, 2002.
   PubMed Web of Science ®Google Scholar
• Tonon S, Picconi M, Bos P, Zinovich J, Galuppo J, et al.: Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. J Clin Virol 21, 129–134, 2001.
   PubMed Web of Science ®Google Scholar
• Ueda Y, Enomoto T, Miyatake T, Ozaki K, Yoshizaki T, et al.: Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia. Lab Investig 83, 1517–1527, 2003..
   PubMed Web of Science ®Google Scholar